Healthcare -
Biotechnology - NASDAQ - US
$ 13.719
3.54 %
$ 199 M
Market Cap
0.11
P/E
INBX - COST OF REVENUE
Cost of Revenue INBX - Inhibrx Biosciences, Inc.
1.19 M
LAST VALUE
-33.44%
2 YEAR CAGR
-48.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR